Home / Resource Library / Tumor metabolic heterogeneity based on 18F-FDG PET/CT is a predictor of outcome in diffuse large B-cell lymphoma

Tumor metabolic heterogeneity based on 18F-FDG PET/CT is a predictor of outcome in diffuse large B-cell lymphoma

Study investigated tumour metabolic heterogeneity in DLBCL.